Here, we demonstrated the indispensable roles of FOXA1 on the emergence of cells tolerant to osimertinib via IGF-1R activation associated with increased mRNA and protein expression of IGF-1R in AXL-low-expressing EGFR-mutated NSCLC cells following osimertinib exposure. Here, FOXA1 is linked to non-small cell lung carcinoma.